Literature DB >> 15338055

Global gene expression of fission yeast in response to cisplatin.

L Gatti1, D Chen, G L Beretta, G Rustici, N Carenini, E Corna, D Colangelo, F Zunino, J Bähler, P Perego.   

Abstract

The cellular response to the antitumor drug cisplatin is complex, and resistance is widespread. To gain insights into the global transcriptional response and mechanisms of resistance, we used microarrays to examine the fission yeast cell response to cisplatin. In two isogenic strains with differing drug sensitivity, cisplatin activated a stress response involving glutathione-S-transferase, heat shock, and recombinational repair genes. Genes required for proteasome-mediated protein degradation were up-regulated in the sensitive strain, whereas genes for DNA damage recognition/repair and for mitotic progression were induced in the resistant strain. The response to cisplatin overlaps in part with the responses to cadmium and the DNA-damaging agent methylmethane sulfonate. The different gene groups involved in the cellular response to cisplatin help the cells to tolerate and repair DNA damage and to overcome cell cycle blocks. These findings are discussed with respect to known cisplatin response pathways in human cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338055     DOI: 10.1007/s00018-004-4218-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  23 in total

Review 1.  A review of anabolic steroids: uses and effects.

Authors:  M LaBree
Journal:  J Sports Med Phys Fitness       Date:  1991-12       Impact factor: 1.637

2.  Androgenic anabolic steroids and arterial structure and function in male bodybuilders.

Authors:  M A Sader; K A Griffiths; R J McCredie; D J Handelsman; D S Celermajer
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

Review 3.  Side effects of anabolic androgenic steroids: pathological findings and structure-activity relationships.

Authors:  Andreas Büttner; Detlef Thieme
Journal:  Handb Exp Pharmacol       Date:  2010

4.  Lipid profile of body builders with and without self-administration of anabolic steroids.

Authors:  J Fröhlich; T Kullmer; A Urhausen; R Bergmann; W Kindermann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

Review 5.  Use of steroids for self-enhancement: an epidemiologic/societal perspective.

Authors:  C E Yesalis
Journal:  AIDS Read       Date:  2001-03

Review 6.  The cardiac toxicity of anabolic steroids.

Authors:  M L Sullivan; C M Martinez; P Gennis; E J Gallagher
Journal:  Prog Cardiovasc Dis       Date:  1998 Jul-Aug       Impact factor: 8.194

7.  Cardiac effects of anabolic steroids.

Authors:  J R Payne; P J Kotwinski; H E Montgomery
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

8.  Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?

Authors:  A Urhausen; T Albers; W Kindermann
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 9.  Cardiovascular effects of androgenic-anabolic steroids.

Authors:  R B Melchert; A A Welder
Journal:  Med Sci Sports Exerc       Date:  1995-09       Impact factor: 5.411

10.  Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?

Authors:  Gen Kanayama; Geoffrey H Cohane; Roger D Weiss; Harrison G Pope
Journal:  J Clin Psychiatry       Date:  2003-02       Impact factor: 4.384

View more
  9 in total

Review 1.  Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy.

Authors:  Macus Tien Kuo; Siqing Fu; Niramol Savaraj; Helen H W Chen
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

2.  Interaction of Epe1 with the heterochromatin assembly pathway in Schizosaccharomyces pombe.

Authors:  Sara Isaac; Julian Walfridsson; Tal Zohar; David Lazar; Tamar Kahan; Karl Ekwall; Amikam Cohen
Journal:  Genetics       Date:  2007-04       Impact factor: 4.562

3.  Regulation of transcriptome, translation, and proteome in response to environmental stress in fission yeast.

Authors:  Daniel H Lackner; Michael W Schmidt; Shuangding Wu; Dieter A Wolf; Jürg Bähler
Journal:  Genome Biol       Date:  2012-04-18       Impact factor: 13.583

4.  Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast.

Authors:  Laura Gatti; Kwang L Hoe; Jacqueline Hayles; Sabina C Righetti; Nives Carenini; Laura Dal Bo; Dong U Kim; Han O Park; Paola Perego
Journal:  BMC Genomics       Date:  2011-01-19       Impact factor: 3.969

5.  Podbat: a novel genomic tool reveals Swr1-independent H2A.Z incorporation at gene coding sequences through epigenetic meta-analysis.

Authors:  Laia Sadeghi; Carolina Bonilla; Annelie Strålfors; Karl Ekwall; J Peter Svensson
Journal:  PLoS Comput Biol       Date:  2011-08-25       Impact factor: 4.475

6.  Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach.

Authors:  Navin Sarin; Florian Engel; Florian Rothweiler; Jindrich Cinatl; Martin Michaelis; Roland Frötschl; Holger Fröhlich; Ganna V Kalayda
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

7.  Simplified primer design for PCR-based gene targeting and microarray primer database: two web tools for fission yeast.

Authors:  Christopher J Penkett; Zoë E Birtle; Jürg Bähler
Journal:  Yeast       Date:  2006-10-15       Impact factor: 3.239

8.  Multiple pathways differentially regulate global oxidative stress responses in fission yeast.

Authors:  Dongrong Chen; Caroline R M Wilkinson; Stephen Watt; Christopher J Penkett; W Mark Toone; Nic Jones; Jürg Bähler
Journal:  Mol Biol Cell       Date:  2007-11-14       Impact factor: 4.138

9.  Genomic expression patterns in cell separation mutants of Schizosaccharomyces pombe defective in the genes sep10 ( + ) and sep15 ( + ) coding for the Mediator subunits Med31 and Med8.

Authors:  Ida Miklos; Zsolt Szilagyi; Stephen Watt; Erika Zilahi; Gyula Batta; Zsuzsa Antunovics; Klara Enczi; Jürg Bähler; Matthias Sipiczki
Journal:  Mol Genet Genomics       Date:  2007-10-07       Impact factor: 3.291

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.